×
Back to Agenda
S3-2 - What’s new in ICH guidelines? (2)
Session Chair(s)
Myounghee Kim
Senior Director, Clinical Operations, IQVIA Korea, Korea, Republic of
Nayoung Lee, MBA
Vice president, Commercial APAC, PAREXEL, Korea, Republic of
Speaker(s)
Nan Wang, PHD
Head, Asia Medical Writing, GSK, China
Bongkyoo Choi, MPH, RPH
Sr. Research Fellow/Head/Vice President, R&D Dept., GC Biopharma, AI & Data Science Center, Korea, Republic of
General Principles on Planning, Designing, Analysing, and Reporting of Non-interventional Studies that Utilize Real-World Data for Safety Assessment of Medicines
Young Su Noh, PHD
Director, Head of Clinical Research and Development, Hanmi Pharmaceuticals , Korea, Republic of
E22: General Consideration for Patient Preference Studies
Have an account?